Literature DB >> 17317753

Loss of caveolin-3 induced by the dystrophy-associated P104L mutation impairs L-type calcium channel function in mouse skeletal muscle cells.

Harold Couchoux1, Bruno Allard, Claude Legrand, Vincent Jacquemond, Christine Berthier.   

Abstract

Caveolins are membrane scaffolding proteins that associate with and regulate a variety of signalling proteins, including ion channels. A deficiency in caveolin-3 (Cav-3), the major striated muscle isoform, is responsible for skeletal muscle disorders, such as limb-girdle muscular dystrophy 1C (LGMD 1C). The molecular mechanisms leading to the muscle wasting that characterizes this pathology are poorly understood. Here we show that a loss of Cav-3 induced by the expression of the LGMD 1C-associated mutant P104L (Cav-3(P104L)) provokes a reduction by half of the maximal conductance of the voltage-dependent L-type Ca(2+) channel in mouse primary cultured myotubes and fetal skeletal muscle fibres. Confocal immunomiscrocopy indicated a colocalization of Cav-3 and Ca(v)1.1, the pore-forming subunit of the L-type Ca(2+) channel, at the surface membrane and in the developing T-tubule network in control myotubes and fetal fibres. In myotubes expressing Cav-3(P104L), the loss of Cav-3 was accompanied by a 66% reduction in Ca(v)1.1 mean labelling intensity. Our results suggest that Cav-3 is involved in L-type Ca(2+) channel membrane function and localization in skeletal muscle cells and that an alteration of L-type Ca(2+) channels could be involved in the physiopathological mechanisms of caveolinopathies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17317753      PMCID: PMC2075458          DOI: 10.1113/jphysiol.2006.124198

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  46 in total

1.  Biogenesis of transverse tubules in skeletal muscle in vitro.

Authors:  B E Flucher; M Terasaki; H M Chin; T J Beeler; M P Daniels
Journal:  Dev Biol       Date:  1991-05       Impact factor: 3.582

2.  Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease.

Authors:  R C Betz; B G Schoser; D Kasper; K Ricker; A Ramírez; V Stein; T Torbergsen; Y A Lee; M M Nöthen; T F Wienker; J P Malin; P Propping; A Reis; W Mortier; T J Jentsch; M Vorgerd; C Kubisch
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

3.  Developmental regulation of expression of the alpha 1 and alpha 2 subunits mRNAs of the voltage-dependent calcium channel in a differentiating myogenic cell line.

Authors:  G Varadi; J Orlowski; A Schwartz
Journal:  FEBS Lett       Date:  1989-07-03       Impact factor: 4.124

4.  Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity.

Authors:  Y Sunada; H Ohi; A Hase; H Ohi; T Hosono; S Arata; S Higuchi; K Matsumura; T Shimizu
Journal:  Hum Mol Genet       Date:  2001-02-01       Impact factor: 6.150

5.  Sequential docking, molecular differentiation, and positioning of T-Tubule/SR junctions in developing mouse skeletal muscle.

Authors:  H Takekura; B E Flucher; C Franzini-Armstrong
Journal:  Dev Biol       Date:  2001-11-15       Impact factor: 3.582

6.  Elevated subsarcolemmal Ca2+ in mdx mouse skeletal muscle fibers detected with Ca2+-activated K+ channels.

Authors:  N Mallouk; V Jacquemond; B Allard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

7.  The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.

Authors:  C Matsuda; Y K Hayashi; M Ogawa; M Aoki; K Murayama; I Nishino; I Nonaka; K Arahata; R H Brown
Journal:  Hum Mol Genet       Date:  2001-08-15       Impact factor: 6.150

8.  Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency.

Authors:  Carlo Minetti; Massimo Bado; Paolo Broda; Federica Sotgia; Claudio Bruno; Ferruccio Galbiati; Daniela Volonte; Giuseppe Lucania; Antonio Pavan; Eduardo Bonilla; Michael P Lisanti; Giuseppe Cordone
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

9.  Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.

Authors:  F Galbiati; J A Engelman; D Volonte; X L Zhang; C Minetti; M Li; H Hou; B Kneitz; W Edelmann; M P Lisanti
Journal:  J Biol Chem       Date:  2001-03-19       Impact factor: 5.157

10.  Subcellular distribution of the 1,4-dihydropyridine receptor in rabbit skeletal muscle in situ: an immunofluorescence and immunocolloidal gold-labeling study.

Authors:  A O Jorgensen; A C Shen; W Arnold; A T Leung; K P Campbell
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more
  14 in total

Review 1.  Caveolin proteins and estrogen signaling in the brain.

Authors:  Jessie I Luoma; Marissa I Boulware; Paul G Mermelstein
Journal:  Mol Cell Endocrinol       Date:  2008-04-22       Impact factor: 4.102

2.  In vivo expression of G-protein beta1gamma2 dimer in adult mouse skeletal muscle alters L-type calcium current and excitation-contraction coupling.

Authors:  Norbert Weiss; Claude Legrand; Sandrine Pouvreau; Hicham Bichraoui; Bruno Allard; Gerald W Zamponi; Michel De Waard; Vincent Jacquemond
Journal:  J Physiol       Date:  2010-06-14       Impact factor: 5.182

3.  A family with discordance between malignant hyperthermia susceptibility and rippling muscle disease.

Authors:  Jimmy Sundblom; Atle Melberg; Franz Rücker; Anja Smits; Gunilla Islander
Journal:  J Anesth       Date:  2012-09-14       Impact factor: 2.078

Review 4.  Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.

Authors:  Christian Plank; Olivier Zelphati; Olga Mykhaylyk
Journal:  Adv Drug Deliv Rev       Date:  2011-08-26       Impact factor: 15.470

Review 5.  Caveolin regulation of neuronal intracellular signaling.

Authors:  Christopher M Stern; Paul G Mermelstein
Journal:  Cell Mol Life Sci       Date:  2010-07-15       Impact factor: 9.261

6.  Caveolin-3 associates with and affects the function of hyperpolarization-activated cyclic nucleotide-gated channel 4.

Authors:  Bin Ye; Ravi C Balijepalli; Jason D Foell; Stacie Kroboth; Qi Ye; Yu-Hong Luo; Nian-Qing Shi
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

7.  Caveolin 3 is associated with the calcium release complex and is modified via in vivo triadin modification.

Authors:  Stéphane Vassilopoulos; Sarah Oddoux; Séverine Groh; Marine Cacheux; Julien Fauré; Julie Brocard; Kevin P Campbell; Isabelle Marty
Journal:  Biochemistry       Date:  2010-07-27       Impact factor: 3.162

8.  Expression of the muscular dystrophy-associated caveolin-3(P104L) mutant in adult mouse skeletal muscle specifically alters the Ca(2+) channel function of the dihydropyridine receptor.

Authors:  Norbert Weiss; Harold Couchoux; Claude Legrand; Christine Berthier; Bruno Allard; Vincent Jacquemond
Journal:  Pflugers Arch       Date:  2008-05-29       Impact factor: 3.657

9.  The interaction of caveolin 3 protein with the potassium inward rectifier channel Kir2.1: physiology and pathology related to long qt syndrome 9 (LQT9).

Authors:  Ravi Vaidyanathan; Amanda L Vega; Chunhua Song; Qing Zhou; Bi-Hua Tan; Bihua Tan; Stuart Berger; Jonathan C Makielski; Lee L Eckhardt
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

10.  Characterization of the molecular architecture of human caveolin-3 and interaction with the skeletal muscle ryanodine receptor.

Authors:  Gareth Whiteley; Richard F Collins; Ashraf Kitmitto
Journal:  J Biol Chem       Date:  2012-10-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.